NCT07590349

Brief Summary

Stroke is a leading cause of long-term disability worldwide, with upper-limb impairment representing a major determinant of functional limitation and reduced independence. Conventional rehabilitation approaches are often limited by accessibility, intensity, and long-term adherence, highlighting the need for innovative, home-based solutions. This study aims to evaluate the effectiveness of a personalized robotic telerehabilitation program for upper-limb recovery in individuals with post-stroke motor impairment. The intervention combines a wearable robotic device with a virtual reality-based platform, enabling patients to perform structured, task-oriented exercises in a home environment under remote supervision. Participants will be allocated to either a robotic-assisted telerehabilitation program or a control condition based on virtual reality-based rehabilitation alone. Motor recovery will be assessed using standardized clinical scales, including the Fugl-Meyer Assessment for Upper Extremity (FMA-UE), along with measures of functional performance, patient-reported outcomes, and treatment adherence. By integrating robotic assistance with telemedicine, this study seeks to enhance rehabilitation intensity, improve patient engagement, and facilitate continuity of care beyond traditional clinical settings. The results are expected to support the development of accessible, personalized rehabilitation pathways for individuals with stroke-related upper-limb disability.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
12mo left

Started Jun 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 8, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 15, 2026

Completed
17 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2027

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2027

Last Updated

May 15, 2026

Status Verified

May 1, 2026

Enrollment Period

12 months

First QC Date

May 8, 2026

Last Update Submit

May 14, 2026

Conditions

Keywords

strokeRoboticsTelerehabilitationHemiplegia

Outcome Measures

Primary Outcomes (1)

  • Change in upper-limb motor function assessed by the Fugl-Meyer Assessment for Upper Extremity (FMA-UE)

    The primary outcome is the change in upper-limb motor function measured using the Fugl-Meyer Assessment for Upper Extremity (FMA-UE), comparing baseline (pre-intervention) and post-treatment values. The FMA-UE is a validated, stroke-specific scale that evaluates motor recovery and functional impairment of the upper limb.

    Baseline to 4 weeks

Secondary Outcomes (9)

  • Box and Block Test (BBT)

    Baseline to 4 weeks

  • Functional independence

    Baseline to 4 weeks

  • Pain intensity and interference

    Baseline to 4 weeks

  • Stroke-related quality of life

    Baseline to 4 weeks

  • Muscle strength

    Baseline to 4 weeks

  • +4 more secondary outcomes

Study Arms (2)

Robotic-Assisted Telerehabilitation for Upper Limb Recovery

EXPERIMENTAL

Participants assigned to this arm will receive a home-based telerehabilitation program supported by a wearable robotic device integrated with a virtual reality-based rehabilitation platform. The intervention consists of daily 60-minute sessions over a 4-week period and includes passive and active-assisted upper-limb mobilization, grasping and releasing exercises, task-oriented activities, and interactive exergaming exercises. All sessions will be remotely supervised by a physiotherapist, with individualized adjustments based on participant performance and progression.

Device: Robotic-Assisted Telerehabilitation Virtual Reality-Based Telerehabilitation

Virtual Reality Telerehabilitation Without Robotic Support

ACTIVE COMPARATOR

Participants assigned to this arm will receive a home-based telerehabilitation program delivered through a virtual reality-based rehabilitation platform. The intervention consists of daily 60-minute sessions over a 4-week period and includes upper-limb mobilization exercises, task-oriented training, and interactive exergaming activities. All sessions will be remotely supervised by a physiotherapist to ensure correct execution and adherence to the rehabilitation protocol.

Other: Virtual reality-based rehabilitation platform without robotic assistance

Interventions

Experimental: Robotic-Assisted Telerehabilitation for Upper Limb Recovery Arm Description: Participants assigned to the experimental group will receive a home-based telerehabilitation program supported by a wearable robotic device integrated with a virtual reality-based rehabilitation platform. The intervention consists of daily 60-minute sessions over a 4-week period, including passive and active-assisted upper-limb mobilization, task-oriented exercises, and exergaming activities, with remote supervision by a physiotherapist.

Robotic-Assisted Telerehabilitation for Upper Limb Recovery

Active Comparator: Virtual Reality Telerehabilitation Without Robotic Support Arm Description: Participants assigned to the control group will receive a home-based telerehabilitation program delivered through a virtual reality-based rehabilitation platform. The intervention consists of daily 60-minute sessions over a 4-week period, including upper-limb mobilization exercises, task-oriented training, and interactive exergaming activities. All sessions will be remotely supervised by a physiotherapist to ensure correct execution and adherence to the protocol.

Virtual Reality Telerehabilitation Without Robotic Support

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 years or older
  • Diagnosis of stroke with residual upper-limb motor impairment
  • Upper-limb functional impairment defined by a Fugl-Meyer Assessment for Upper Extremity (FMA-UE) score between 20 and 50
  • Ability to understand study procedures and provide written informed consent
  • Availability of a home environment suitable for telerehabilitation

You may not qualify if:

  • Presence of severe neurological or musculoskeletal disorders affecting the upper limb
  • Severe spasticity (Modified Ashworth Scale ≥3)
  • Severe upper-limb pain (Numerical Rating Scale \>4)
  • Skin lesions, infections, or conditions preventing safe use of wearable devices
  • Participation in another interventional clinical trial
  • Any medical or cognitive condition that may interfere with compliance or safe participation in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Langhorne P, Bernhardt J, Kwakkel G. Stroke rehabilitation. Lancet. 2011 May 14;377(9778):1693-702. doi: 10.1016/S0140-6736(11)60325-5.

    PMID: 21571152BACKGROUND
  • GBD 2019 Acute and Chronic Care Collaborators. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019. Nat Commun. 2025 May 7;16(1):4235. doi: 10.1038/s41467-025-56910-x.

    PMID: 40335470BACKGROUND

MeSH Terms

Conditions

StrokeParesisHemiplegia

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsParalysis

Central Study Contacts

MARCO PAOLETTA, Researcher

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
This study is designed as an open-label trial with no masking. Due to the nature of the interventions, participants and study personnel (including therapists and investigators) cannot be blinded to group allocation. Participants in the experimental group will use a wearable robotic device integrated with a virtual reality-based telerehabilitation platform, while participants in the control group will receive virtual reality-based telerehabilitation alone. The clear differences between interventions make blinding unfeasible. Outcome assessments will be based on standardized clinical scales and objective measures to minimize potential assessment bias.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomized to either robotic-assisted telerehabilitation or virtual reality-based telerehabilitation alone in a parallel-group design. Both interventions will be delivered in a home-based setting with remote supervision over 4 weeks to compare their effects on upper-limb recovery after stroke.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

May 8, 2026

First Posted

May 15, 2026

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

May 30, 2027

Study Completion (Estimated)

May 30, 2027

Last Updated

May 15, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

Individual participant data underlying the results will be shared with researchers upon reasonable request, following publication of the study results. Data will be de-identified in accordance with applicable data protection regulations.

Shared Documents
STUDY PROTOCOL
Time Frame
Starting 6 months after publication of the primary results; ending 5 years after publication.